Company Details
genetic-engineering-&-biotechnology-news
296
180,985
511
genengnews.com
0
GEN_2541941
In-progress

Genetic Engineering & Biotechnology News Company CyberSecurity Posture
genengnews.comGenetic Engineering & Biotechnology News (GEN) is the flagship publication of Mary Ann Liebert, Inc. Celebrating its 40th anniversary in 2021, GEN was the first publication in this field and remains the key driver in the explosion of the industry, paving the way for the development of new tools and technologies, investment growth, and career opportunities. Through its cornerstone Magazine, dynamic Website, high-frequency eNewsletters, and innovative suite of multimedia, GEN is the 360-degree resource that researchers and executives depend on for information that is pivotal for their success. GEN’s breadth of editorial coverage is unrivaled, providing exclusive reporting, insight, and analysis across the life sciences – from its five foundational pillars of Drug Discovery, Bioprocessing, OMICS, Translational Medicine, and Gene Editing to a new, expanded focus on the emerging areas of Cancer Research, Infectious Diseases, and Artificial Intelligence. Within these areas, GEN delivers exclusive, high-quality reporting on the latest industry news; insider information on cutting-edge tools and technologies; industry-standard protocols, tutorials, and technical articles; first-looks at emerging industry collaborations and investments; reports from key scientific and industry meetings; and A-Lists, our monthly insight and analysis into the top companies, products, and movers & shakers impacting the industry today.
Company Details
genetic-engineering-&-biotechnology-news
296
180,985
511
genengnews.com
0
GEN_2541941
In-progress
Between 750 and 799

GEBN Global Score (TPRM)XXXX



No incidents recorded for Genetic Engineering & Biotechnology News in 2025.
No incidents recorded for Genetic Engineering & Biotechnology News in 2025.
No incidents recorded for Genetic Engineering & Biotechnology News in 2025.
GEBN cyber incidents detection timeline including parent company and subsidiaries

Genetic Engineering & Biotechnology News (GEN) is the flagship publication of Mary Ann Liebert, Inc. Celebrating its 40th anniversary in 2021, GEN was the first publication in this field and remains the key driver in the explosion of the industry, paving the way for the development of new tools and technologies, investment growth, and career opportunities. Through its cornerstone Magazine, dynamic Website, high-frequency eNewsletters, and innovative suite of multimedia, GEN is the 360-degree resource that researchers and executives depend on for information that is pivotal for their success. GEN’s breadth of editorial coverage is unrivaled, providing exclusive reporting, insight, and analysis across the life sciences – from its five foundational pillars of Drug Discovery, Bioprocessing, OMICS, Translational Medicine, and Gene Editing to a new, expanded focus on the emerging areas of Cancer Research, Infectious Diseases, and Artificial Intelligence. Within these areas, GEN delivers exclusive, high-quality reporting on the latest industry news; insider information on cutting-edge tools and technologies; industry-standard protocols, tutorials, and technical articles; first-looks at emerging industry collaborations and investments; reports from key scientific and industry meetings; and A-Lists, our monthly insight and analysis into the top companies, products, and movers & shakers impacting the industry today.


Who We Are Risk & Insurance® covers the people, stories and risks that embody the essential functions of risk management and commercial insurance. What We Do Some people think of risk management and commercial insurance as staid and dull. Even some insurance executives believe their industry is inf

XAMonline, Inc. has been publishing high-quality study guides since 1996. We are committed to providing the best study guides / exam preparation tools available on the market to enable students and professionals to achieve their education and career goals. We are proud to have helped over 1.5m

For three decades, AY has been Arkansas’ premier magazine. We share the stories that matter to Arkansans: real stories about real people making an impact in their communities, the state and even the world. AY is a leader in our state as we consistently deliver content that resonates with our readers

Our Mission Dark Moon Press is a small, indie publisher dedicated to dark, daring and bizarre literature. As a publisher, partnered with authors, our mission is to teach people that differences could be positive and frightening unknowns are merely adventures-in-waiting. What We Do Our dedic

Stable Media, is a division of Stable Publishing Ltd, an independent publisher of market leading business to business magazines. Launched in 1990 by Managing Director Toby Filby, the company has now grown to a multiplatform media provider involved in the built environment across leisure, educatio

ST Media Group International leverages unparalleled and trusted information to deliver the highest quality audience to the vendors in our markets. Recognized worldwide as the #1 educator, authority, and voice for the visual communications markets, ST Media Group International Inc. has been keepin
.png)
Joshua Lederberg, Nobel laureate and president of Rockefeller University, is well known in biology circles. Not so his wife, Dr. Esther...
An international team of researchers has used genetic engineering to create so-called 'product-ready' antivenom for snakes such as cobras...
In recent advancements in the realm of genetic engineering, a pivotal study has emerged that focuses on the development of knockout cardiac...
What if the genome you were born with wasn't fixed? Eric Kelsic, CEO of Dyno Therapeutics, explains how gene therapy is moving from promise...
Rewriting the Future of Genetics: How Genome Editing Is Powering the Next Biotech Revolution.
Gene-edited crops are no safer than GMOs, and fast-tracking regulatory approval could trigger a costly backlash.
In a groundbreaking study published in BMC Genomics, researchers have unveiled the remarkable potential of the transcription factor AtDREB1A...
Parliament is considering updating the technicalities and definitions of "genetic modification". The issue is a sensitive one, both for food...
This academic-industry partnership reflects the need for a multidisciplinary approach to innovation in cell and gene therapy manufacturing.

Explore insights on cybersecurity incidents, risk posture, and Rankiteo's assessments.
The official website of Genetic Engineering & Biotechnology News is http://www.genengnews.com.
According to Rankiteo, Genetic Engineering & Biotechnology News’s AI-generated cybersecurity score is 757, reflecting their Fair security posture.
According to Rankiteo, Genetic Engineering & Biotechnology News currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.
According to Rankiteo, Genetic Engineering & Biotechnology News is not certified under SOC 2 Type 1.
According to Rankiteo, Genetic Engineering & Biotechnology News does not hold a SOC 2 Type 2 certification.
According to Rankiteo, Genetic Engineering & Biotechnology News is not listed as GDPR compliant.
According to Rankiteo, Genetic Engineering & Biotechnology News does not currently maintain PCI DSS compliance.
According to Rankiteo, Genetic Engineering & Biotechnology News is not compliant with HIPAA regulations.
According to Rankiteo,Genetic Engineering & Biotechnology News is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.
Genetic Engineering & Biotechnology News operates primarily in the Book and Periodical Publishing industry.
Genetic Engineering & Biotechnology News employs approximately 296 people worldwide.
Genetic Engineering & Biotechnology News presently has no subsidiaries across any sectors.
Genetic Engineering & Biotechnology News’s official LinkedIn profile has approximately 180,985 followers.
No, Genetic Engineering & Biotechnology News does not have a profile on Crunchbase.
Yes, Genetic Engineering & Biotechnology News maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/genetic-engineering-&-biotechnology-news.
As of November 28, 2025, Rankiteo reports that Genetic Engineering & Biotechnology News has not experienced any cybersecurity incidents.
Genetic Engineering & Biotechnology News has an estimated 4,881 peer or competitor companies worldwide.
Total Incidents: According to Rankiteo, Genetic Engineering & Biotechnology News has faced 0 incidents in the past.
Incident Types: The types of cybersecurity incidents that have occurred include .
.png)
ThingsBoard in versions prior to v4.2.1 allows an authenticated user to upload malicious SVG images via the "Image Gallery", leading to a Stored Cross-Site Scripting (XSS) vulnerability. The exploit can be triggered when any user accesses the public API endpoint of the malicious SVG images, or if the malicious images are embedded in an `iframe` element, during a widget creation, deployed to any page of the platform (e.g., dashboards), and accessed during normal operations. The vulnerability resides in the `ImageController`, which fails to restrict the execution of JavaScript code when an image is loaded by the user's browser. This vulnerability can lead to the execution of malicious code in the context of other users' sessions, potentially compromising their accounts and allowing unauthorized actions.
Mattermost versions 11.0.x <= 11.0.2, 10.12.x <= 10.12.1, 10.11.x <= 10.11.4, 10.5.x <= 10.5.12 fail to to verify that the token used during the code exchange originates from the same authentication flow, which allows an authenticated user to perform account takeover via a specially crafted email address used when switching authentication methods and sending a request to the /users/login/sso/code-exchange endpoint. The vulnerability requires ExperimentalEnableAuthenticationTransfer to be enabled (default: enabled) and RequireEmailVerification to be disabled (default: disabled).
Mattermost versions 11.0.x <= 11.0.2, 10.12.x <= 10.12.1, 10.11.x <= 10.11.4, 10.5.x <= 10.5.12 fail to sanitize team email addresses to be visible only to Team Admins, which allows any authenticated user to view team email addresses via the GET /api/v4/channels/{channel_id}/common_teams endpoint
Exposure of email service credentials to users without administrative rights in Devolutions Server.This issue affects Devolutions Server: before 2025.2.21, before 2025.3.9.
Exposure of credentials in unintended requests in Devolutions Server.This issue affects Server: through 2025.2.20, through 2025.3.8.

Get company history
Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.
Identify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.
Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.
Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.
Leverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.